Home > Cashflow Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹-0.72 Cr₹7.03 Cr₹1.61 Cr₹0.85 Cr₹17 Cr

What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?

The latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) is ₹-0.72 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹-0.72 Cr
Mar2022₹7.03 Cr
Mar2021₹1.61 Cr
Mar2020₹0.85 Cr
Mar2019₹17 Cr

How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹-0.72 Cr
Negative
Mar2022 ₹7.03 Cr
335.44
Mar2021 ₹1.61 Cr
89.88
Mar2020 ₹0.85 Cr
-94.96
Mar2019 ₹17 Cr -

Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹577.3 Cr 1.1% -2% 103.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,920.0 Cr -2.3% -6.5% 55.3% Stock Analytics
CIPLA ₹113,794.0 Cr 4.1% -4.8% 55.6% Stock Analytics
DIVIS LABORATORIES ₹106,860.0 Cr 7.8% 17.4% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,316.0 Cr 4% 0.8% 29.4% Stock Analytics
ZYDUS LIFESCIENCES ₹95,380.9 Cr -1.2% -5.2% 83.9% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

1.1%

-2%

103.4%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses